SCHEMBL24860681

SCHEMBL24860681

COc1cc(-c2cscc2Br)cc(OC)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ GAA P10253 1/20 0.41
▸ FYN P06241 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ BRD4 O60885 3/20 0.40
▸ TSHR P16473 1/20 0.40
▸ APOBEC3A P31941 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ APOBEC3G Q9HC16 1/20 0.40
▸ CA9 Q16790 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ TUBB1 Q9H4B7 4/20 0.39
▸ TUBB4A P04350 2/20 0.39
▸ TUBB P07437 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24860680 0.87 ACHE (0.48) GAAFYNACHEKDM4EALDH1A1
SCHEMBL24860583 0.76 EPHB4 (0.54) FYNACHEALDH1A1TUBB1TUBB4A
SCHEMBL721861 0.71 ACHE (0.65) GAAFYNACHEKDM4EALDH1A1
SCHEMBL2037227 0.70 PTGS2 (0.56) MAOBALDH1A1CA9MAPTCA12
SCHEMBL2976498 0.69 — —
SCHEMBL29234155 0.68 ERN1 (0.58) ACHEKDM4EALDH1A1HPGDL3MBTL1
Ammonia Solution, Strong SCHEMBL6204421 0.68 FYN (0.52) GAAFYNACHEKDM4EALDH1A1
SCHEMBL429756 0.67 ACHE (0.59) ACHEKDM4EALDH1A1HPGDL3MBTL1
Ethyne SCHEMBL29254174 0.66 FYN (0.50) GAAFYNACHEKDM4EALDH1A1
SCHEMBL7253177 0.66 ESR1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150919-A1 Method for Producing Mono-Cross-Coupled Aromatic Compound Having Leaving Group NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2023-05-18 — — US disclosed
US-20230150919-A1 Method for Producing Mono-Cross-Coupled Aromatic Compound Having Leaving Group NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2023-05-18 — — US disclosed
EP-4116282-A1 METHOD FOR PRODUCING MONO-CROSS-COUPLED AROMATIC COMPOUND HAVING LEAVING GROUP National University Corporation Hokkaido University (JP) 2023-01-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150919-A1 Method for Producing Mono-Cross-Coupled Aromatic Compound Having Leaving Group DDC, PAH, ATIC MAOA 63/4885MAOB 57/4885GAA 3422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback